Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 22.1 Reduced beta cell mass in type 2 diabetic patients, as compared to non-diabetic controls, although there is a marked inter-subject variability.

Similar presentations


Presentation on theme: "Fig. 22.1 Reduced beta cell mass in type 2 diabetic patients, as compared to non-diabetic controls, although there is a marked inter-subject variability."— Presentation transcript:

1 Fig Reduced beta cell mass in type 2 diabetic patients, as compared to non-diabetic controls, although there is a marked inter-subject variability and clear overlap between the two groups (adapted from [21]) The Islets of Langerhans, Islam, Md. Shahidul (Ed.) ISBN: , Springer

2 Fig Isolated type 2 diabetic (T2DM) islets show Increased apoptosis and enhanced caspase-3 and caspase-8 activities in isolated type 2 diabetic (T2DM) islets, as compared to non-diabetic controls. Adapted from [22] The Islets of Langerhans, Islam, Md. Shahidul (Ed.) ISBN: , Springer

3 Fig ATP production and ATP/ADP ratio increase in non-diabetic but not in type 2 diabetic islets following exposure to 3.3–16.7 mmol/l glucose concentration. Adapted from [27] The Islets of Langerhans, Islam, Md. Shahidul (Ed.) ISBN: , Springer

4 Fig A significant induction of genes involved in endoplasmic reticulum stress (BiP and XBP-1t) in isolated type 2 diabetic islets at increased glucose concentration. Adapted from [23] The Islets of Langerhans, Islam, Md. Shahidul (Ed.) ISBN: , Springer

5 Fig Figure demonstrating the increased the amount of insulin granules in type 2 diabetic beta cells that are pre-exposed to metformin (reproduced with modifications from [22]) The Islets of Langerhans, Islam, Md. Shahidul (Ed.) ISBN: , Springer


Download ppt "Fig. 22.1 Reduced beta cell mass in type 2 diabetic patients, as compared to non-diabetic controls, although there is a marked inter-subject variability."

Similar presentations


Ads by Google